School of Medicine
Showing 11-20 of 22 Results
-
Joseph (Joe) Lipsick
Professor of Pathology, of Genetics and, by courtesy, of Biology
Current Research and Scholarly Interests Function and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Scott Lovell
Postdoctoral Research Fellow, Pathology
Bio Scott received his B.S. in Chemistry from the University of Sheffield in the summer of 2013. As part of his bachelor?s degree he worked for AstraZeneca from Sept 2011 ? Aug 2012 as an organic synthetic chemist. In 2019 he earned his Ph.D. in Chemical Biology from Imperial College London where he worked with Prof. Edward Tate. His thesis focused on developing covalent inhibitors for KLK proteases to decipher their role in prostate cancer progression. Having joined the Bogyo lab in October 2019, Scott now works on developing selective inhibitors and substrates for serine hydrolases in cancer and pathogenic bacteria by using diverse chemical libraries and phage-display approaches.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology at the Stanford University Medical Center
Bio Dr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of CTC technology to improve clinical diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly Interests We are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimer’s and Parkinson’s diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Katherine L. Lucot
Postdoctoral Research Fellow, Pathology
Bio Katie is interested in translational genomics using animals as models for human diseases, with an emphasis on neurodegenerative diseases and early detection.
